Background Since its approval in 2017 for the treatment of diabetes, semaglutide, also known by its brand names Ozempic, Rybelsus and Wegovy, all manufactured by Novo Nordisk, has become one of the most popular prescription drugs in the U.S., Pew Research reported
In fact, when you look at some of the clinical research, users are just eating fewer candy bars but theyre still eating candy bars. Badaracco listed what she called GLP-1 meal allies that product developers can use when formulating products for GLP-1 users
However, such approaches often yield limited results, as they fail to address the underlying biological mechanisms driving weight gain
Improvements in energy, blood sugar, cardiovascular health, mobility, and confidence are equally important markers of progress
Cycling strategies that incorporate off-cycle periods may be preferable to continuous long-term use, possibly offering better safety profiles while still allowing extended research durations